Machine Learning

A novel triple-action topical spray for male pattern baldness enters a pivotal clinical trial, potentially disrupting a multi-billion dollar market.

A new Australian-funded program will train women in cybersecurity in Fiji, Samoa, and Tonga, aiming to bolster regional defenses and promote gender equality.

A Utah fintech just landed a massive credit line to disrupt the luxury auto market. Here's how its AI platform is changing the game for car collectors.

Boston-based Reclaim Health wins a top AI award for its platform that automatically finds and recovers millions in medical billing errors for employers and staff.

With FDA clearance, Zeto New Wave™ promises to slash EEG wait times and ease staff shortages, making critical brain health data more accessible.

The classic internet speed test is obsolete. A new standard, TR-471, is shifting focus to what matters: latency, jitter, and reliability under load.

With FDA clearance for clinical trials, CanWell Pharma’s novel CAN016 ADC brings a two-pronged attack against drug-resistant HER2-positive cancers.

A new fintech partnership aims to provide personal loans to a vast, underserved market of Canadians with thin or non-existent credit histories.

AvenCell has dosed the first patient with AVC-203, a novel allogeneic CAR-T therapy, aiming to make advanced cancer treatment more accessible and effective.

LALIGA becomes the first European league to partner with a prediction market in North America, a bold move into a legally complex, high-stakes world.

Scientists propose a unifying model combining 'viral mimicry' and 'cancer dark matter,' potentially revolutionizing how our immune system recognizes and fights tumors.

Tired of ineffective hair gummies? A new biotech firm backed by Khosla Ventures claims its 'pill-strength' gummy delivers real results in 30 days.

productronica Shanghai 2026 reveals a new era of smart factories, where AI, embodied intelligence, and autonomous systems are reshaping global production.

With international sales now making up nearly 60% of its revenue, the heavy industry giant is diversifying into humanoid robots and emerging markets.

US AI firm Larx opens a UK subsidiary led by a military veteran, aiming to deliver 'decision intelligence' to allied defense and intelligence partners.

With key hires from Flatiron and Syneos, Target RWE signals major scaling plans in the booming real-world evidence market under new ownership.

SINTRONES showcases rugged, cyber-secure Edge AI at Japan IT Week, revealing how certified platforms are protecting critical infrastructure.

The EdTech firm reports a 63% surge in free cash flow, leveraging AI innovation to offset headwinds from a cooling U.S. K-12 market.

With a new patent for its drug ALPHA-1062, Alpha Cognition may become a first-mover in the $14 billion traumatic brain injury market, which has no approved therapies.

HubSpot adds MongoDB CFO Mike Berry to its board, a strategic move to bolster financial discipline and guide its ambitious AI-driven global expansion.